As of January 1st, 2020, the HTCNV has become the statewide lead for the HRSA Sickle Cell Disease Treatment Demonstration Program (SCDTDP) grant.
As a participant of the Pacific Sickle Cell Regional Collaborative (PSCRC), the SCCNV aims to:
Improve accessibility to quality, coordinated, & comprehensive SCD health care services for affected individuals.
Strengthen the network of knowledgeable providers utilizing evidence based practices.
Expand data collection and processing to document regional improvements in access, capacity, & outcomes.
